Related Experiment Video
Updated: May 31, 2026

08:35
High Throughput Danio Rerio Energy Expenditure Assay
Published on: January 27, 2016
Zebrafish obesogenic test: a tool for screening molecules that target adiposity
Angèle Tingaud-Sequeira1, Nafia Ouadah, Patrick J Babin
1Maladies Rares: Génétique et Métabolisme, University Bordeaux, Talence, France.
Journal of Lipid Research
|July 5, 2011
Summary
The novel zebrafish obesogenic (ZO) test identifies compounds that cause obesity. This whole-organism assay screens for obesogenic and anti-obesogenic substances, aiding environmental and human risk assessments.
Area of Science:
- Endocrinology
- Toxicology
- Aquatic Biology
Background:
- Dietary and environmental factors can disrupt endocrine signaling and lipid metabolism, contributing to obesity.
- Existing research methods for obesity assessment include in vitro assays and rodent models.
- There is a need for intermediate, whole-organism assays to evaluate obesogenic compounds.
Purpose of the Study:
- To introduce and validate the zebrafish obesogenic (ZO) test, a novel short-term assay for assessing obesogenic and anti-obesogenic compounds.
- To evaluate the efficacy of the ZO test in identifying environmental toxicants and pharmaceutical compounds that affect white adipose tissue (WAT) dynamics.
- To establish the ZO test as a valuable tool for environmental and human risk assessment.
Main Methods:
- The zebrafish obesogenic (ZO) test utilizes live zebrafish larvae and the Nile Red (NR) fluorescent probe to visualize and quantify adipocyte lipid droplets.
- The assay assesses white adipose tissue (WAT) dynamics and overall adiposity in response to various compounds, including environmental contaminants and drugs.
- Larvae were exposed to environmentally relevant concentrations of tributyltin chloride (TBT) and other known obesogenic or anti-obesogenic compounds.
Main Results:
- Zebrafish larvae exposed to tributyltin chloride (TBT) showed a significant increase in adiposity, regardless of dietary lipid content.
- The ZO test successfully classified known obesogenic compounds (e.g., rosiglitazone, TBT) and anti-obesogenic compounds.
- The assay demonstrated sensitivity to compounds affecting adiposity in a manner consistent with their known effects in other models.
Conclusions:
- The zebrafish obesogenic (ZO) test is a validated whole-organism assay for screening obesogenic and anti-obesogenic compounds.
- The ZO test provides a valuable intermediate step between in vitro and rodent assays for obesity research.
- This assay offers relevant data for assessing the risks of environmental toxicants and pharmaceutical compounds to both aquatic species and humans.

